Spectral AI, Inc.
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked…
1D
-1.9%
1W
-8.5%
1M
-2.6%
6M
-20.1%
YTD
+6.3%
1Y
-38.6%
2Y
+17.1%
5Y
-84.5%
10Y
–
Next earnings date
10/11/2026 (in 24 days)
Volatility around earnings
~12% weaker price swings than usual
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 14/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BearishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
PRICE TARGET LOW
US$4.00
CONSENSUS
US$4.00
MEDIAN
US$4.00
PRICE TARGET HIGH
US$4.00
0
STRONG BUY
2
BUY
0
HOLD
0
SELL
0
STRONG SELL
2
TOTAL · Buy
As of: 27/05/2026
P/E
-4.33
P/B
-4.02
EV/EBITDA
-6.22
RETURN ON EQUITY
34.6%
NET MARGIN
-118.5%
DEBT/EQUITY
-1.35
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
71.5%
FLOAT SHARES
23,002,708
AVG. DAILY VOLUME (30D)
134,001
DiMaio John Michael
DiMaio John Michael
DiMaio John Michael
DiMaio John Michael
DiMaio John Michael
Spectral AI, Inc. is a company in the Healthcare sector, Medical - Specialties industry, headquartered in United States.
The CEO is Vincent S. Capone, the company employs around 65 people.
The IPO was on 06/04/2021; the stock trades on NASDAQ under the ticker MDAI.
2 analysts rate the stock, the consensus is Buy (as of 27/05/2026).
The average price target is US$4.00, ranging from US$4.00 to US$4.00, with a median of US$4.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 10/11/2026.
Around past earnings, price swings were roughly -12% stronger than usual.
No, Spectral AI currently does not pay a dividend.
Comparable stocks include STERIS, QuidelOrtho, Mesa Laboratories, 908 Devices, Trinity Biotech, Eli Lilly and Company, Johnson & Johnson and AbbVie.
Clicking "Analyze stock" lets five strategies assess Spectral AI against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.